These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 16165388)

  • 1. Use of handheld computers for assessment of prefrontal cortex function in patients with phenylketonuria.
    Bik-Multanowski M; Mozrzymas R; Nowacka M; Borawska-Kowalczyk U; Lange A; Starostecka E; Didycz B; Kaluzny L; Gizewska M; Szynaka E; Szymczakiewicz-Multanowska A;
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S142-4. PubMed ID: 16165388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis.
    Albrecht J; Garbade SF; Burgard P
    Neurosci Biobehav Rev; 2009 Mar; 33(3):414-21. PubMed ID: 19038285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of computerized neuropsychological tests and of nuclear magnetic resonance spectroscopy in clinical assessment of adult patients with phenylketonuria].
    Bik-Multanowski M; Pietrzyk JJ
    Przegl Lek; 2011; 68(3):127-31. PubMed ID: 21812225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine use of CANTAB system for detection of neuropsychological deficits in patients with PKU.
    Bik-Multanowski M; Pietrzyk JJ; Mozrzymas R
    Mol Genet Metab; 2011 Feb; 102(2):210-3. PubMed ID: 21035369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection of behavioral side effects of antiepileptic treatment using handheld computers.
    Frings L; Wagner K; Maiwald T; Carius A; Schinkel A; Lehmann C; Schulze-Bonhage A
    Epilepsy Behav; 2008 Aug; 13(2):402-6. PubMed ID: 18539084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prefrontal dysfunction model of early-treated phenylketonuria.
    Welsh MC
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S87-9. PubMed ID: 8828618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
    Sharman R; Sullivan K; Young R; McGill J
    Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using medical knowledge sources on handheld computers--a qualitative study among junior doctors.
    Axelson C; Wårdh I; Strender LE; Nilsson G
    Med Teach; 2007 Sep; 29(6):611-8. PubMed ID: 17978970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cognitive dysfunctions in patients with alcohol dependence].
    Nowakowska K; Jabłkowska K; Borkowska A
    Psychiatr Pol; 2007; 41(5):693-702. PubMed ID: 18421924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain phenylalanine measurement in patients with phenylketonuria: a serious diagnostic method or just reading tea leaves?
    Bik-Multanowski M; Pietrzyk JJ
    Mol Genet Metab; 2007 Jul; 91(3):297-8. PubMed ID: 17482495
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of modafinil on prefrontal executive function in schizophrenia.
    Hunter MD; Ganesan V; Wilkinson ID; Spence SA
    Am J Psychiatry; 2006 Dec; 163(12):2184-6. PubMed ID: 17151173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Executive functioning in children and adolescents with phenylketonuria.
    VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
    Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of L-dopa on pattern visual evoked potentials (P-100) and neuropsychological tests in untreated adult patients with phenylketonuria.
    Ullrich K; Weglage J; Oberwittler C; Pietsch M; Fünders B; van Eckhardstein H; Colombo JP
    J Inherit Metab Dis; 1994; 17(3):349-52. PubMed ID: 7807950
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuropsychological frontal impairments and negative symptoms in schizophrenia.
    Martino DJ; Bucay D; Butman JT; Allegri RF
    Psychiatry Res; 2007 Aug; 152(2-3):121-8. PubMed ID: 17507100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene.
    Rybakowski JK; Borkowska A; Skibinska M; Szczepankiewicz A; Kapelski P; Leszczynska-Rodziewicz A; Czerski PM; Hauser J
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):70-6. PubMed ID: 16472361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal cortex dysfunction in patients with suicidal behavior.
    Raust A; Slama F; Mathieu F; Roy I; Chenu A; Koncke D; Fouques D; Jollant F; Jouvent E; Courtet P; Leboyer M; Bellivier F
    Psychol Med; 2007 Mar; 37(3):411-9. PubMed ID: 17049103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global and regional volume changes in the brains of patients with phenylketonuria.
    Pérez-Dueñas B; Pujol J; Soriano-Mas C; Ortiz H; Artuch R; Vilaseca MA; Campistol J
    Neurology; 2006 Apr; 66(7):1074-8. PubMed ID: 16606920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociable roles of prefrontal subregions in self-ordered working memory performance.
    Chase HW; Clark L; Sahakian BJ; Bullmore ET; Robbins TW
    Neuropsychologia; 2008 Sep; 46(11):2650-61. PubMed ID: 18556028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory and prefrontal functions in earthquake survivors: differences between current and past post-traumatic stress disorder patients.
    Eren-Koçak E; Kiliç C; Aydin I; Hizli FG
    Acta Psychiatr Scand; 2009 Jan; 119(1):35-44. PubMed ID: 18853946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the prefrontal function during a cognitive task and the severity of the symptoms in patients with panic disorder: a multi-channel NIRS study.
    Nishimura Y; Tanii H; Hara N; Inoue K; Kaiya H; Nishida A; Okada M; Okazaki Y
    Psychiatry Res; 2009 May; 172(2):168-72. PubMed ID: 19324535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.